logo

For the Inventor, By the Inventor

Birmingham, AL, United States of America

Biocryst Pharmaceuticals, Inc.


USPTO Granted Patents = 92

% Expired Patents = 3.3



Trademarks = 1

Forward Citations = 944

Loading Chart...
Loading Chart...

53 inventors (with patents filed for the assignee):

goldMedal Yarlagadda Sudhakara Babu (75 out of 78 patents)

silverMedal Pravin L Kotian (50 out of 51 patents)

bronzeMedal V Satish Kumar (31 out of 31 patents)

4.  Minwan Wu (30 out of 30 patents)

5.  Weihe Zhang (28 out of 40 patents)

6.  Pooran Chand (25 out of 31 patents)

7.  Venkat R Chintareddy (22 out of 22 patents)

8.  Yahya El-Kattan (18 out of 18 patents)

9.  Shanta Bantia (17 out of 21 patents)

10.  Krishnan Raman (12 out of 12 patents)

11.  John A Montgomery (10 out of 60 patents)

12.  Peng-Cheng Lu (8 out of 8 patents)

13.  Zhao Dang (8 out of 8 patents)

14.  Lakshminarayana Vogeti (8 out of 21 patents)

15.  Wei Lv (6 out of 6 patents)


Core Competencies:
Plasma Kallikrein Inhibitors
Antiviral Treatments
Zika Virus
Complement Inhibitors
Hematologic Cancers
ALK2 Kinase
Azasugar Triphosphate
Biaryl Compounds
Nucleoside Analogs
Prodrugs
Therapeutic Agents
Polymerase Inhibition

92 patents:

1. 12679843 - Pyrrolopyrimidine amines as complement inhibitors (2026-07-14),
2. 12590069 - Crystalline salts of a plasma kallikrein inhibitor (2026-03-31),
3. 12590068 - Crystalline salts of a plasma kallikrein inhibitor (2026-03-31),
4. 12589093 - Plasma kallikrein inhibitors and methods of use thereof in ocular disorders (2026-03-31),
5. 12558341 - Oral complement factor D inhibitors (2026-02-24),
6. 12552827 - Synthesis of an antiviral azasugar triphosphate (2026-02-17),
7. 12552750 - Crystalline salts of a plasma kallikrein inhibitor (2026-02-17),
8. 12545647 - Crystalline salts of a plasma kallikrein inhibitor (2026-02-10),
9. 12545646 - Crystalline salts of a plasma kallikrein inhibitor (2026-02-10),
10. 12545645 - Crystalline salts of a plasma kallikrein inhibitor (2026-02-10),
11. 12503443 - Process-scale synthesis of a plasma kallikrein inhibitor (2025-12-23),
12. 12485109 - Pyrrolo 12.3-dipyrimidine compounds and analogues thereof (2025-12-02),
13. 12344585 - Crystalline salts of a plasma kallikrein inhibitor (2025-07-01),
14. 12162838 - Human plasma kallikrein inhibitors (2024-12-10),
15. 12121503 - Antiviral treatments (2024-10-22),
Biocryst Pharmaceuticals, Inc. is a biotechnology company based in Birmingham, Alabama, specializing in the development of innovative therapies for rare diseases. The company focuses on plasma kallikrein inhibitors and antiviral treatments, with research extending to areas such as hematologic cancers and the Zika virus. Biocryst's expertise includes complement inhibitors and novel compounds like azasugar triphosphate and biaryl compounds, positioning it at the forefront of therapeutic advancements in its field.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Biocryst Pharmaceuticals, Inc.
92 Patents

#4 in Birmingham, AL

#15 in Alabama

#4,073 in US

#8,367 in the World

Birmingham, AL (US)
Birmingham, AL, United States of America

Biocryst Pharmaceuticals, Inc.

Forward Citations = 944

53 inventors:

goldMedal Yarlagadda Sudhakara Babu (75 out of 78 patents)

silverMedal Pravin L Kotian (50 out of 51 patents)

bronzeMedal V Satish Kumar (31 out of 31 patents)

4.  Minwan Wu (30 out of 30 patents)

5.  Weihe Zhang (28 out of 40 patents)

Please report any incorrect information to [email protected]
Loading…